This suggests that CTSD represents a common molecular pathology amongst both short- and long-lived ALS patients, while increases in UCHL1 and GPNMB in short-lived represent more aggressive molecular etiologies. The gene discussed is UCHL1; the disease is amyotrophic lateral sclerosis.